Ramsay Health Care (DE:RMY)
FRANKFURT:RMY
RMY Stock Chart & Stats
€24.80
€0.00(0.00%)
At close: 4:00 PM EST
€24.80
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€17.10 - €26.60
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€5.07B
Enterprise Value€25.59B
Total Cash (Recent Filing)€469.00M
Total Debt (Recent Filing)€17.53B
Price to Earnings (P/E)29.1
Beta0.66
Next Earnings
Aug 27, 2026EPS Estimate
0.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.18
Shares Outstanding230,829,800
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-12.47
Price to Book (P/B)5.91
Price to Sales (P/S)1.67
P/FCF Ratio42.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€24.37Price Target Upside-1.72% Downside
Rating ConsensusHold
Number of Analyst Covering5
EPS Forecast (FY)0.83
Revenue Forecast (FY)€11.58B
Bulls Say, Bears Say
Bulls Say
Australia Operating MomentumSustained Australia growth drives group fundamentals: rising admissions, core surgical admissions +5.7% and theatre utilisation +1.3% indicate durable volume expansion and mix improvement. A 40bp EBIT margin lift (ex-Joondalup) supports longer-term earnings resilience from its largest market.
Improved Cash GenerationStronger operating cash flow and positive free cash flow growth strengthen liquidity and reduce reliance on capital markets. Better cash conversion supports capex, dividend policy and turnaround investments, giving management durable flexibility to fund operations and deleveraging over the next several quarters.
Capital Discipline And Portfolio ActionsManagement is actively de‑risking via targeted capex cuts, refinancing to lower funding cost and a proposed Ramsay Sante demerger. These structural moves improve capital allocation, simplify group focus, and can materially lower consolidated leverage and execution complexity over a multi‑quarter horizon.
Bears Say
High Leverage And Debt ConcentrationMaterial consolidated debt and concentrated leverage at Ramsay Sante increase refinancing, interest rate and liquidity risk. Even with hedging and recent refinancings, elevated gross leverage limits strategic flexibility, raises financing costs sensitivity and constrains capacity for acquisitions or prolonged turnarounds.
Compressed Profitability And ROE CollapseSharp deterioration in net margin and ROE signals structural pressure on profitability from cost inflation, payor indexation gaps and underperforming assets. Low returns limit reinvestment and raise the bar for operational improvement needed to restore shareholder returns and sustain dividend policy long term.
Regional Funding And Operational HeadwindsExposure to public payor funding and underperforming subsidiaries creates durable downside. Continued NHS funding uncertainty, Elysium occupancy decline and French subsidy/tax pressures mean persistent volume and margin risk in major markets, complicating group recovery and margin resilience.
Ramsay Health Care News
RMY FAQ
What was Ramsay Health Care’s price range in the past 12 months?
Ramsay Health Care lowest stock price was €17.10 and its highest was €26.60 in the past 12 months.
What is Ramsay Health Care’s market cap?
Ramsay Health Care’s market cap is €5.07B.
When is Ramsay Health Care’s upcoming earnings report date?
Ramsay Health Care’s upcoming earnings report date is Aug 27, 2026 which is in 82 days.
How were Ramsay Health Care’s earnings last quarter?
Ramsay Health Care released its earnings results on Feb 25, 2026. The company reported €0.437 earnings per share for the quarter, beating the consensus estimate of €0.368 by €0.07.
Is Ramsay Health Care overvalued?
According to Wall Street analysts Ramsay Health Care’s price is currently Overvalued.
Does Ramsay Health Care pay dividends?
Ramsay Health Care does not currently pay dividends.
What is Ramsay Health Care’s EPS estimate?
Ramsay Health Care’s EPS estimate is 0.4.
How many shares outstanding does Ramsay Health Care have?
Ramsay Health Care has 230,829,800 shares outstanding.
What happened to Ramsay Health Care’s price movement after its last earnings report?
Ramsay Health Care reported an EPS of €0.437 in its last earnings report, beating expectations of €0.368. Following the earnings report the stock price went up 10.528%.
Which hedge fund is a major shareholder of Ramsay Health Care?
Currently, no hedge funds are holding shares in DE:RMY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ramsay Health Care Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€24.37 (-1.72% Downside)
€24.37 (-1.72% Downside)
Blogger Sentiment
Bullish
DE:RMY Sentiment 83%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth €404.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-9.08%
12-Months-Change
Fundamentals
Return on Equity
5.75%
Trailing 12-Months
Asset Growth
13.13%
Trailing 12-Months
Company Description
Ramsay Health Care
Ramsay Health Care Limited owns and operates hospitals. The company also offers health care services to public and private patients. It operates facilities in approximately 532 locations in the Asia Pacific, the United Kingdom, France, and Nordics. The company was founded in 1964 and is based in Sydney, Australia.
RMY Company Deck
RMY Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
Positive overall: the call emphasizes strong, broad-based underlying profit growth driven by Australia, improved cash flow, active capital-discipline measures, and material operational progress on the transformation agenda. These positives are tempered by clear and material regional challenges — notably UK NHS funding uncertainty, Elysium underperformance, French funding headwinds and elevated leverage in Ramsay Sante — which management is actively addressing through turnaround programs, refinancing and a proposed demerger. The balance of the narrative is constructive but cautious, with meaningful risks to monitor.View all DE:RMY earnings summariesRMY Stock 12 Month Forecast
Average Price Target
€24.37
▼(-1.72% Downside)
Technical Analysis
Healius Limited
―
Regis Healthcare Ltd.
―
Sonic Healthcare Limited
―
Integral Diagnostics Ltd.
―
Australian Clinical Labs Ltd
―
Options Prices
Currently, No data available
---